March 17, 2017
MRC gives £2.8M to six consortium partners for Rheumatoid Arthritis research
Oxford BioDynamics is one of six consortium partners to examine and address why immune-mediated inflammatory diseases (IMIDs) remit and relapse, with a particular focus on Rheumatoid Arthritis (RA).